Related Experiment Video
Updated: Sep 23, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Novel coumarin derivatives of heterocyclic compounds as lipid-lowering agents
Gurram R Madhavan1, Vadla Balraju, Bejugam Mallesham
1Discovery Chemistry, Dr. Reddy's Discovery Research, Bollarum Road, Miyapur, Hyderabad 500050, India. madhavangr@drreddys.com
Abstract:
Coumarin derivatives of different heterocycles (5,7a-i, 10 and 11) were designed based on cyclisation of 2-ethoxy-3-phenylpropanoic acid and 2-benzylmalonic acid as novel lipid-lowering agents and their preliminary in vivo screening indicates 7c has moderate triglyceride-lowering activity.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Cardiovascular Drugs: Classification based on Therapeutic Indications
Pharmacogenomics: Identification of New Drug Targets
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
